RZLT: 6 of 8 upLIFT Patients Meet Primary Endpoint, 100% Discontinue IV Glucose
Rezolute, Inc. Common Stock (NV) · PHARMACEUTICAL PREPARATIONS · Now $3.30
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS